SCHEMBL6548348

SCHEMBL6548348

CCON=C(c1ccccc1)c1ccc(OCCCOc2c(Cl)cc(OCC=C(Cl)Cl)cc2Cl)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PPARG P37231 7/20 0.35
PPARA Q07869 7/20 0.35
ESR1 P03372 4/20 0.34
HTT P42858 2/20 0.34
KCNH2 Q12809 2/20 0.34
EBP Q15125 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
CHRM2 P08172 2/20 0.34
ADRA2A P08913 2/20 0.34
ADORA3 P0DMS8 2/20 0.34
CHRM1 P11229 2/20 0.34
PTGS1 P23219 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
DRD3 P35462 2/20 0.34
HTR6 P50406 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7628012 0.89 TBXAS1 (0.36) MAPK1L3MBTL1PPARGPPARAMAPT
SCHEMBL7624569 0.88 TBXAS1 (0.36) PPARGPPARAESR1MAPTPSEN1
SCHEMBL6548606 0.88 MAPT (0.43) LMNAMAPK1L3MBTL1PPARGPPARA
SCHEMBL6548681 0.87 HTT (0.39) ALDH1A1L3MBTL1HTTKMT2AMEN1
SCHEMBL6548907 0.86 L3MBTL1 (0.36) ALDH1A1LMNAL3MBTL1HTTKDM4E
SCHEMBL6549758 0.85 MAPT (0.43) ALDH1A1LMNAL3MBTL1PPARGPPARA
SCHEMBL13606723 0.85 CYP1A2 (0.34) HTTCYP2D6
SCHEMBL3964031 0.85 CYP1A2 (0.34) HTTCYP2D6
SCHEMBL7624607 0.85 PSEN1 (0.39) PPARGPPARAESR1PSEN1PSEN2
SCHEMBL6548597 0.85 HTT (0.39) LMNAL3MBTL1PPARGPPARAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0975586-B1 OXIME COMPOUNDS, THEIR USE, AND INTERMEDIATES FOR THEIR PRODUCTION SUMITOMO CHEMICAL CO (JP) 2004-12-01 EP disclosed
US-6448444-B2 INSECTICIDES, MITICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-09-10 US disclosed
US-20020019569-A1 Oxime compounds, their use, and intermediates for their production SUMITOMO CHEMICAL COMPANY, LIMITED 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019569-A1 Oxime compounds, their use, and intermediates for their production CBR3, CBR1, NOX3 ALDH1A1 513/4885LMNA 3205/4885MAPK1 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.